117574-35-3

Basic information

• Product Name: 2-[1-(pyridin-3-yl)pentyl]-3,5,6-trimethyl-1,4-benzoquinone
• Synonyms: 2-[1-(pyridin-3-yl)pentyl]-3,5,6-trimethyl-1,4-benzoquinone
• CAS NO: 117574-35-3
• Molecular Weight: 297.397
• Mol File: 117574-35-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-[1-(pyridin-3-yl)pentyl]-3,5,6-trimethyl-1,4-benzoquinone(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[1-(pyridin-3-yl)pentyl]-3,5,6-trimethyl-1,4-benzoquinone(117574-35-3)
• EPA Substance Registry System: 2-[1-(pyridin-3-yl)pentyl]-3,5,6-trimethyl-1,4-benzoquinone(117574-35-3)

Safety Data

• Hazardous Substances Data: 117574-35-3(Hazardous Substances Data)

Upstream product

• 129813-41-8 3-[1-(2,5-Dimethoxy-3,4,6-trimethyl-phenyl)-pentyl]-pyridine 
• 1701-72-0 1-(pyridin-3-yl)pentan-1-one 
• 110-59-8 pentanonitrile 
• 129813-39-4 3-[(Z)-1-(2,5-Dimethoxy-3,4,6-trimethyl-phenyl)-pent-1-enyl]-pyridine 
• 129813-36-1 1-(2,5-Dimethoxy-3,4,6-trimethyl-phenyl)-1-pyridin-3-yl-pentan-1-ol 

Relevant articles and documents

Quinone derivatives, their production and use.

Quinone derivatives represented by the general formula (wherein, R1 and R2, which are the same or different, refer to a hydrogen atom, methyl or methoxymethyl group, or R1 and R2 bind together to form-CH=CH-CH=CH-; R3 is a hydrogen atom or methyl group; R? is a nitrogen-containing heterocyclic group which may be substituted; R? is a hydrogen atom, methyl group, hydroxymethyl group which may be substituted, or a carboxyl group which may be (wherein, R' is a hydrogen atom or methyl group); n is an integer from 0 through 12, m is an integer from 0 through 3, and k is an integer from 0 through 7, providing that, when m is 2 or 3, Z and k are able to vary appropri-ately in the repeating unit shown in [ ] ), and the hydro-quinone derivatives thereof, are novel compounds, possess improvement effects of metabolism of poly unsaturated fatty acids, particularly two or more of inhibition of production of fatty acid peroxides, inhibition of production of metabo-lites in 5-lipoxygenase pathway, inhibition of thromboxane A? synthetase, thromboxane A? receptor antagonism and scavenging action of active oxygen species, and of use as drugs, such as antithrombotics, anti-vascular constriction agents, anti-asthma agent, antiallergic agents, therapeutics for psoriasis, agents for improvement in heart, brain and cardiovascular systems, therapeutics for nephritis, active oxygen-eliminating agents, anticancer agents, agents for improvement of control of arachidonate cascade products, etc.

Certain benzoquinones, naphthoquinones, corresponding hydroquinones which exhibit thromboxane A2 synthetase inhibition or receptor antagonism and the like

Quinone derivatives represented by the general formula STR1 (wherein, R1 and R2, the same or different, refer to a hydrogen atom, methyl or methoxymethyl group, or R1 and R2 bind together to form --CH=CH--CH=CH--; R3 is a hydrogen atom or methyl group; R4 is a nitrogen-containing heterocyclic group which may be substituted; R5 is a hydrogen atom, methyl group, hydroxymethyl group which may be substituted, or a carboxyl group which may be esterified or amidated; Z is STR2 (wherein, R' is hydrogen atom or methyl group); n is an integer from 0 through 12, m is an integer from 0 through 3, and k is an integer from 0 through 7, providing that, when m is 2 or 3, Z and k are able to vary appropriately in the repeating unit shown in [ ]), and the hydroquinone derivatives thereof, are novel compounds, possess improvement effects of metabolism of polyunsaturated fatty acids, particularly two or more of inhibition of production of fatty acid peroxides, inhibition of production of metabolites in 5-lipoxygenase pathway, inhibition of thromboxane A2 synthetase, thromboxane A2 receptor antagonism and scavenging action of active oxygen species, and of use as drugs, such as antithrombotics, anti-vascular constriction agents, anti-asthma agent, antiallergic agents, therapeutics for psoriasis, agents for improvement in heart, brain and cardiovascular systems, therapeutics for nephritis, active oxygen-eliminating agents, anticancer agents, agents for improvement of control of arachidonate cascade products, etc.